A
ARGENX NV ADR
NASDAQ: ARGX (argenx SE)
Kemas kini terakhir: 48 minit lalu623.82
-2.21 (-0.35%)
| Penutupan Terdahulu | 626.03 |
| Buka | 623.20 |
| Jumlah Dagangan | 264,391 |
| Purata Dagangan (3B) | 271,376 |
| Modal Pasaran | 37,302,128,640 |
| Harga / Pendapatan (P/E Ke hadapan) | 101.01 |
| Harga / Jualan (P/S) | 20.68 |
| Harga / Buku (P/B) | 8.52 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 27 Feb 2025 |
| Margin Keuntungan | -2.11% |
| Margin Operasi (TTM) | 2.75% |
| EPS Cair (TTM) | -0.790 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 73.30% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 0.80% |
| Nisbah Semasa (MRQ) | 8.53 |
| Aliran Tunai Operasi (OCF TTM) | -259.55 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -223.88 M |
| Pulangan Atas Aset (ROA TTM) | -5.51% |
| Pulangan Atas Ekuiti (ROE TTM) | -5.74% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Bercampur |
| Biotechnology (Global) | Bercampur | Bercampur | |
| Stok | argenx SE | Menaik | Menaik |
AISkor Stockmoo
1.4
| Konsensus Penganalisis | 1.5 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -0.5 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | 2.0 |
| Purata | 1.38 |
|
Argenx is a Dutch company focused on using its antibody engineering technology to treat rare autoimmune diseases. Vyvgart (efgartigimod) was initially approved in the US in December 2021 as a treatment for generalized myasthenia gravis, followed by approvals in Europe and Japan in 2022. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Mid Growth |
| % Dimiliki oleh Institusi | 59.76% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 723.00 (Wells Fargo, 15.90%) | Beli |
| Median | 662.50 (6.20%) | |
| Rendah | 605.00 (Raymond James, -3.02%) | Beli |
| Purata | 660.29 (5.85%) | |
| Jumlah | 13 Beli, 1 Pegang | |
| Harga Purata @ Panggilan | 588.30 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Wells Fargo | 19 Dec 2024 | 723.00 (15.90%) | Beli | 626.03 |
| 01 Nov 2024 | 639.00 (2.43%) | Beli | 595.58 | |
| Evercore ISI Group | 21 Nov 2024 | 706.00 (13.17%) | Beli | 596.74 |
| Oppenheimer | 21 Nov 2024 | 675.00 (8.20%) | Beli | 596.74 |
| 01 Nov 2024 | 646.00 (3.56%) | Beli | 595.58 | |
| HC Wainwright & Co. | 20 Nov 2024 | 617.00 (-1.09%) | Beli | 591.82 |
| 01 Nov 2024 | 617.00 (-1.09%) | Beli | 595.58 | |
| Wolfe Research | 12 Nov 2024 | 697.00 (11.73%) | Beli | 593.95 |
| Scotiabank | 05 Nov 2024 | 715.00 (14.62%) | Beli | 602.47 |
| JP Morgan | 04 Nov 2024 | 670.00 (7.40%) | Beli | 588.67 |
| Baird | 01 Nov 2024 | 650.00 (4.20%) | Pegang | 595.58 |
| Guggenheim | 01 Nov 2024 | 665.00 (6.60%) | Beli | 595.58 |
| 26 Sep 2024 | 585.00 (-6.22%) | Beli | 524.58 | |
| JMP Securities | 01 Nov 2024 | 606.00 (-2.86%) | Beli | 595.58 |
| Piper Sandler | 01 Nov 2024 | 620.00 (-0.61%) | Beli | 595.58 |
| Truist Securities | 31 Oct 2024 | 660.00 (5.80%) | Beli | 586.30 |
| Citigroup | 17 Oct 2024 | 635.00 (1.79%) | Beli | 543.84 |
| Raymond James | 10 Oct 2024 | 605.00 (-3.02%) | Beli | 527.25 |
| Papar semua | ||||
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2024 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |